Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-11-23 19:43:11 UTC |
---|
Updated at | 2021-08-19 23:59:31 UTC |
---|
NP-MRD ID | NP0002901 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Neostigmine |
---|
Provided By | BMRB |
---|
Description | Neostigmine, also known as proserine or synstigmin, belongs to the class of organic compounds known as phenoxy compounds. These are aromatic compounds contaning a phenoxy group. Neostigmine was first documented in 1982 (PMID: 7200780). Based on a literature review a small amount of articles have been published on Neostigmine (PMID: 8584207) (PMID: 34601981) (PMID: 34599343). |
---|
Structure | CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1 |
---|
Synonyms | Value | Source |
---|
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate | ChEBI | 3-Trimethylammoniumphenyl N,N-dimethylcarbamate | ChEBI | Eustigmin | ChEBI | Eustigmine | ChEBI | m-Trimethylammoniumphenyldimethylcarbamate | ChEBI | Prostigmine | ChEBI | Vagostigmine | ChEBI | Prostigmin | Kegg | (m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid | Generator | 3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid | Generator | m-Trimethylammoniumphenyldimethylcarbamic acid | Generator | Proserine | HMDB | Neostigmine bromide | HMDB | Methylsulfate, neostigmine | HMDB | Polstigmine | HMDB | Syntostigmine | HMDB | Bromide, neostigmine | HMDB | Neostigmine methylsulfate | HMDB | Prozerin | HMDB | Synstigmin | HMDB |
|
---|
Chemical Formula | C12H19N2O2 |
---|
Average Mass | 223.2915 Da |
---|
Monoisotopic Mass | 223.14465 Da |
---|
IUPAC Name | 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium |
---|
Traditional Name | neostigmine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C |
---|
InChI Identifier | InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1 |
---|
InChI Key | ALWKGYPQUAPLQC-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenoxy compounds. These are aromatic compounds contaning a phenoxy group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenoxy compounds |
---|
Direct Parent | Phenoxy compounds |
---|
Alternative Parents | |
---|
Substituents | - Phenoxy compound
- Aniline or substituted anilines
- Quaternary ammonium salt
- Carbamic acid ester
- Carbonic acid derivative
- Amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic salt
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic cation
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Sobek V: The effect of calcium, neostigmine and 4-aminopyridine upon respiratory arrest and depression of cardiovascular functions after aminoglycosidic antibiotics. Arzneimittelforschung. 1982;32(3):222-4. [PubMed:7200780 ]
- Shen E, Sun X: Endogenous acetylcholine-induced Fos expression in magnocellular neurosecretory neurons in the supraoptic nucleus of the rat hypothalamus. Neurosci Lett. 1995 Aug 11;195(3):191-4. doi: 10.1016/0304-3940(95)11816-f. [PubMed:8584207 ]
- Hile GB, Healy KJ, Almassalkhi LR: Rocuronium Reversal in the Emergency Department: Retrospective Evaluation of Hemodynamic Instability Following Administration of Sugammadex Versus Neostigmine With Glycopyrrolate. J Pharm Pract. 2021 Oct 2:8971900211048747. doi: 10.1177/08971900211048747. [PubMed:34601981 ]
- Deng J, Balouch M, Albrink M, Camporesi EM: Sugammadex Reduces PACU Recovery Time after Abdominal Surgery Compared with Neostigmine. South Med J. 2021 Oct;114(10):644-648. doi: 10.14423/SMJ.0000000000001304. [PubMed:34599343 ]
|
---|